Global Mechanical Thrombectomy Devices Market Driven by Innovation: Set to Surge with 6% Growth in the Next 5 Years

 

Growing number of cases of stroke and venous thromboembolism (deep vein thrombosis and pulmonary embolism), as well as the approval/launch of novel mechanical thrombectomy devices, favorable clinical trial outcomes with mechanical thrombectomy, and acquisitions by leading players to strengthen their vascular portfolio and treat patients with blood clots, are driving the growth of the mechanical thrombectomy devices market.

Blood clots are a prevalent medical problem that need rapid medical intervention. Mechanical thrombectomy devices are utilized in operations to treat blood clot-caused arterial blockages. Mechanical thrombectomy can be used to treat ischemic stroke, pulmonary embolism (PE), and deep vein thrombosis (DVT).

Technological Advances in Mechanical Thrombectomy Drive Market Growth for Mechanical Thrombectomy Devices

Constant technical advances and innovations are projected to drive the global mechanical thrombectomy devices market. As an example,

  • In April 2022, Penumbra announced that its Indigo Aspiration System with Lightning 7 and Lightning 12 has secured CE Mark and are now commercially available in Europe. Both technologies are part of Penumbra’s Indigo Aspiration System - now with Intelligent Aspiration for mechanical thrombectomy -and are designed for single-session arterial and venous thrombus removal, including the treatment of pulmonary embolisms.

“Existing mechanical thrombectomy treatment options do not adequately treat VTE for several reasons. Most current mechanical thrombectomy devices are designed to aspirate fresher arterial clot, which is small and soft. As a result, these devices can be inadequate and ineffective for removing the larger, older clots associated with VTE.”-General Manager, Commercial-stage Medical Device Company, APAC

The Impact of Covid-19 on the Global Mechanical Thrombectomy Devices Market

Due to Covid-19, the number of elective surgeries decreased dramatically in 2020, resulting in a market reduction. The following are possible explanations for the apparent decrease in mechanical thrombectomy performance throughout 2020-2021:

  • Delays in accessing specialized care, resulting in patients presenting outside of the therapeutic window.
  • Reluctance of acute ischemic stroke patients to present at emergency departments.
  • Reduction in stroke occurrence during the COVID-19 pandemic as a result of mandated social distancing.

However, towards the end of 2021 fourth quarter, companies witnessed the pressure from COVID-19 gradually alleviated and businesses are now trending close to normalized run rates.

Explore Customized  Mechanical Thrombectomy Devices Market Reports @ https://www.globenewswire.com/en/news-release/2022/11/16/2557367/0/en/Global-Mechanical-Thrombectomy-Devices-Market-valued-at-760-million-in-2021-is-set-to-witness-a-healthy-growth-rate-of-6-in-the-next-5-years.html

Competitive Landscape Analysis: Mechanical Thrombectomy Devices Market

The global mechanical thrombectomy devices market is marked by the presence of established industry players such as Medtronic, Stryker, Penumbra, Boston Scientific, AngioDynamics, Control Medical, Inari Medical, among others.

Key Market Players Use Organic and Inorganic Growth Strategies to Establish a Foothold in the Mechanical Thrombectomy Devices Market

To get a bigger market share, the main companies in the mechanical thrombectomy devices market have used both organic and inorganic growth tactics such as acquisitions and new product releases. For instance,

  • In April 2022, Wallaby Medical acquired phenox GmbH. phenox has a broad product portfolio covering both ischemic and hemorrhagic stroke as well as Access & Support. The key product lines of phenox include the p64/p48 range of flow diverters for the treatment of intracranial aneurysms and the pRESET range of stent retrievers for the mechanical thrombectomy of ischemic strokes.

The rising geriatric population and cases of stroke, venous thromboembolism, technological advancements in mechanical thrombectomy devices, strong product pipeline, established coding & payments for mechanical thrombectomy in key markets such as the United States, and growing awareness about mechanical thrombectomy due to patient advocacy groups and clinical society support all bode well for the mechanical thrombectomy devices market.

Get Detailed Insights on Mechanical Thrombectomy Devices Market with a Sample Report @ https://meditechinsights.com/mechanical-thrombectomy-devices-market/

About Medi-Tech Insights:

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services.

 

Contact Us:

Ruta Halde

Associate, Medi-Tech Insights

+32 498 86 80 79

info@meditechinsights.com

Comments

Post a Comment

Popular posts from this blog

The Transplantation Market Anticipated to Expand with 9-10% CAGR by 2029 as Need for Organ Transplants Rises

Image
  The market is propelled by various factors, including advancements in medical technology, the rising prevalence of chronic diseases that lead to organ failure, increasing awareness of transplantation as a viable treatment option, and evolving regulatory and reimbursement policies. In medical terms, transplantation refers to the surgical procedure of transferring cells, tissues, or organs from a donor to a recipient to replace malfunctioning or damaged body parts. Its primary goal is to restore normal function or improve the quality of life for the recipient. Transplantation is often used to treat end-stage organ failure, severe injuries, certain cancers, and congenital defects that are not manageable through other medical treatments. This specialized field requires careful matching of donors and recipients, advanced surgical techniques, and comprehensive post-transplant care to ensure success. Types of transplantation include: Kidney Transplantation: Involves replacing a fail...
Read more

Global 3D Cell Culture Market Seeks Prosperous Horizon: Double-Digit Growth Expected by 2027

Image
  The need for organ transplants and tissue engineering combined with developments in scaffold-free technology, a rise in investments and research and development (R&D) funding for cell-based studies, growing efforts to develop potential alternatives to animal-based testing, and the rising incidence of chronic diseases are some of the major factors propelling the growth of the global 3D cell culture market. 3D cell culture   is an important approach in cell biology and tissue engineering because it includes cultivating and analyzing cells in a three-dimensional environment that mimics the circumstances present in the human body. It has several advantages, such as the capacity to recreate in vivo settings, allow the creation of complex multicellular structures, and give realistic drug testing situations. Scaffold-based technologies employing materials such as hydrogels are employed for 3D cell culturing. Its uses include cancer research, tissue engineering, and medication d...
Read more

Global Tricuspid Valve Repair Market Driven by Innovation: Set to Surge with a US$2.5 Billion Market by 2028

Image
  Increasing geriatric population, growing preference for minimally invasive procedures like annuloplasty and transcatheter tricuspid valve repair (TTVR), increased clinical research and trials activities for developing new tricuspid valve repair technologies, and rising incidence of tricuspid valve disorders are some of the key factors driving the global tricuspid valve repair market. • Medical technology advancements in the field of cardiac interventions. • Improved awareness of heart valve disorders. One of the four valves in our heart that regulates blood flow is the tricuspid valve . It is located between the ventricle and the atrium, the upper and lower chambers of our heart, on the right side. It guarantees that blood travels from the right atrium to the right ventricle in the proper path. As blood passes through the tricuspid valve, its three leaflets, or flaps, open and close. Tricuspid valve illnesses are disorders that some people have that impair the tricuspid valve's a...
Read more